Vivalan, a new anti-depressant-report on an out-patient trial.
The study on 20 patients referred from the psychiatric out-patients of the Jinnah Postgraduate Medical Centre, who were given Vivalan showed marked improvement in 14 patients (70%). Three showed mild improvement while three did not respond. The drug appears to be an advance in the range of anti-depressants presently available. It is of interest to note that Vivalan is not tricyclic compound, nor does it inhibit monoamine oxidase in vitro.
D000275:Adjustment Disorders / Q000188:drug therapy; D000328:Adult; D000368:Aged; D000928:Antidepressive Agents / Q000627:therapeutic use*; D003863:Depression / Q000188:drug therapy*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009025:Morpholines / Q000494:pharmacology*; D012559:Schizophrenia / Q000188:drug therapy*
D000928:Antidepressive Agents; D009025:Morpholines